The optimize project: beyond first-line therapy in metastatic renal cell carcinoma

被引：0
|
作者：
Daniel Castellano
Joaquim Bellmunt
机构：
[1] University Hospital 12 de Octubre,Medical Oncology Department
[2] Hospital Universitario del Mar-IMIM,undefined
来源：
Cancer and Metastasis Reviews | 2012年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 2
页数：1
相关论文
共 50 条
  • [31] Radical shifts in the first-line management of metastatic renal cell carcinoma
    Moshe C. Ornstein
    Brian I. Rini
    [J]. Nature Reviews Clinical Oncology, 2019, 16 : 71 - 72
  • [32] Radical shifts in the first-line management of metastatic renal cell carcinoma
    Ornstein, Moshe C.
    Rini, Brian I.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (02) : 71 - 72
  • [33] Bevacizumab - In first-line treatment of advanced and/or metastatic renal cell carcinoma
    Frampton, James E.
    Keating, Gillian M.
    [J]. BIODRUGS, 2008, 22 (02) : 113 - 120
  • [34] BevacizumabIn First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma
    James E. Frampton
    Gillian M. Keating
    [J]. BioDrugs, 2008, 22 : 113 - 120
  • [35] Recent Advances in First-Line Management of Metastatic Renal Cell Carcinoma
    Dabkara, Deepak
    Biswas, Bivas
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022, 43 (02) : 195 - 200
  • [36] The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma
    Kameda, Tomohiro
    Takayama, Tatsuya
    Sugihara, Toru
    Takeshima, Saki
    Yamazaki, Masahiro
    Komatsubara, Maiko
    Kamei, Jun
    Fujisaki, Akira
    Ando, Satoshi
    Kurokawa, Shinsuke
    Fujimura, Tetsuya
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (04) : 241 - 246
  • [37] First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Roussel, Eduard
    Kinget, Lisa
    Beuselinck, Benoit
    Albersen, Maarten
    Wells, Connor
    Ernst, Matthew Scott
    Donskov, Frede
    Schmidt, Andrew Lachlan
    Szabados, Bernadett
    Pal, Sumanta K.
    Meza, Luis A.
    Agarwal, Neeraj
    Weickhardt, Andrew James
    Davis, Ian D.
    Alva, Ajjai Shivaram
    Wood, Lori
    Porta, Camillo
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Navani, Vishal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [38] Second-Line Treatment Outcomes After First-Line Sunitinib Therapy in Metastatic Renal Cell Carcinoma
    Chen, Chi-Chang
    Hess, Gregory P.
    Liu, Zhimei
    Gesme, Dean H.
    Agarwala, Sanjiv S.
    Garay, Carlos C.
    Hill, Jerrold W.
    Guo, Amy
    [J]. CLINICAL GENITOURINARY CANCER, 2012, 10 (04) : 256 - 261
  • [39] COMPARATIVE EFFECTIVENESS OF FIRST-LINE IMMUNOTHERAPY, TARGETED THERAPY, AND COMBINATION THERAPY FOR METASTATIC CLEAR CELL RENAL CELL CARCINOMA
    Chakiryan, Nicholas
    Jiang, David
    Gillis, Kyle
    Green, Elizabeth
    Hajiran, Ali
    Hugar, Lee
    Zemp, Logan
    Chahoud, Jad
    Zhang, Jingsong
    Jain, Rohit
    Sexton, Wade
    Gilbert, Scott
    Manley, Brandon
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E678 - E678
  • [40] Axitinib beyond first-line therapy of Metastatic Renal Cell Carcinoma: Real World Data from the STAR-TOR registry
    Uhlig, Annemarie
    Uhlig, Johannes
    Woike, Michael
    Fischer, Thomas
    Trojan, Lutz
    Bergmann, Lothar
    Goebell, Peter J.
    Rink, Michael
    Schlack, Katrin
    Leitsmann, Marianne
    Strauss, Arne
    [J]. KIDNEY CANCER, 2023, 7 (01) : 37 - 48
12345